124 related articles for article (PubMed ID: 9191089)
1. Elevated expression of glutathione peroxidase in PC12 cells results in protection against methamphetamine but not MPTP toxicity.
Hom DG; Jiang D; Hong EJ; Mo JQ; Andersen JK
Brain Res Mol Brain Res; 1997 Jun; 46(1-2):154-60. PubMed ID: 9191089
[TBL] [Abstract][Full Text] [Related]
2. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
Fonck C; Baudry M
Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of monoamine oxidase-B results in enhanced neurite degeneration in methamphetamine-treated PC12 cells.
Wei Q; Jurma OP; Andersen JK
J Neurosci Res; 1997 Nov; 50(4):618-26. PubMed ID: 9404723
[TBL] [Abstract][Full Text] [Related]
4. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
Zhang J; Graham DG; Montine TJ; Ho YS
J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
[TBL] [Abstract][Full Text] [Related]
5. Genetic elevation of monoamine oxidase levels in dopaminergic PC12 cells results in increased free radical damage and sensitivity to MPTP.
Wei Q; Yeung M; Jurma OP; Andersen JK
J Neurosci Res; 1996 Dec; 46(6):666-73. PubMed ID: 8978500
[TBL] [Abstract][Full Text] [Related]
6. Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells.
Lee CS; Han ES; Jang YY; Han JH; Ha HW; Kim DE
J Neurochem; 2000 Aug; 75(2):521-31. PubMed ID: 10899927
[TBL] [Abstract][Full Text] [Related]
7. Protection of methamphetamine nigrostriatal toxicity by dietary selenium.
Kim HC; Jhoo WK; Choi DY; Im DH; Shin EJ; Suh JH; Floyd RA; Bing G
Brain Res; 1999 Dec; 851(1-2):76-86. PubMed ID: 10642830
[TBL] [Abstract][Full Text] [Related]
8. Methamphetamine protects against MPTP neurotoxicity in C57BL mice.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Budai G
Eur J Pharmacol; 1994 Jan; 251(2-3):311-4. PubMed ID: 8149986
[TBL] [Abstract][Full Text] [Related]
9. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.
Klivenyi P; Andreassen OA; Ferrante RJ; Dedeoglu A; Mueller G; Lancelot E; Bogdanov M; Andersen JK; Jiang D; Beal MF
J Neurosci; 2000 Jan; 20(1):1-7. PubMed ID: 10627575
[TBL] [Abstract][Full Text] [Related]
10. Effect of melatonin on methamphetamine- and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity and methamphetamine-induced behavioral sensitization.
Itzhak Y; Martin JL; Black MD; Ali SF
Neuropharmacology; 1998 Jun; 37(6):781-91. PubMed ID: 9707292
[TBL] [Abstract][Full Text] [Related]
11. Attenuation of 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine induced nigrostriatal toxicity in mice by N-acetyl cysteine.
Sharma A; Kaur P; Kumar V; Gill KD
Cell Mol Biol (Noisy-le-grand); 2007 Apr; 53(1):48-55. PubMed ID: 17519111
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin restores glutathione peroxidase activity in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced neurotoxicity in C57BL mice and stimulates murine astroglial glutathione peroxidase production in vitro.
Genc S; Akhisaroglu M; Kuralay F; Genc K
Neurosci Lett; 2002 Mar; 321(1-2):73-6. PubMed ID: 11872260
[TBL] [Abstract][Full Text] [Related]
13. Methamphetamine- and 1-methyl-4-phenyl- 1,2,3, 6-tetrahydropyridine-induced dopaminergic neurotoxicity in inducible nitric oxide synthase-deficient mice.
Itzhak Y; Martin JL; Ali SF
Synapse; 1999 Dec; 34(4):305-12. PubMed ID: 10529724
[TBL] [Abstract][Full Text] [Related]
14. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress.
Cubells JF; Rayport S; Rajendran G; Sulzer D
J Neurosci; 1994 Apr; 14(4):2260-71. PubMed ID: 8158268
[TBL] [Abstract][Full Text] [Related]
15. Differential protection against MPTP or methamphetamine toxicity in dopamine neurons by deletion of ppN/OFQ expression.
Brown JM; Gouty S; Iyer V; Rosenberger J; Cox BM
J Neurochem; 2006 Jul; 98(2):495-505. PubMed ID: 16749908
[TBL] [Abstract][Full Text] [Related]
16. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice.
Moy LY; Albers DS; Sonsalla PK
Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931
[TBL] [Abstract][Full Text] [Related]
17. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of lavender oil on scopolamine induced cognitive deficits in mice and H
Xu P; Wang K; Lu C; Dong L; Gao L; Yan M; Aibai S; Liu X
J Ethnopharmacol; 2016 Dec; 193():408-415. PubMed ID: 27558947
[TBL] [Abstract][Full Text] [Related]
19. Obligatory role for complex I inhibition in the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
Richardson JR; Caudle WM; Guillot TS; Watson JL; Nakamaru-Ogiso E; Seo BB; Sherer TB; Greenamyre JT; Yagi T; Matsuno-Yagi A; Miller GW
Toxicol Sci; 2007 Jan; 95(1):196-204. PubMed ID: 17038483
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of the toxicity of the dopaminergic neurotoxins MPTP and MPP+ in PC12 pheochromocytoma cells: binding and biological studies.
Marongiu ME; Piccardi MP; Bernardi F; Corsini GU; Del Zompo M
Neurosci Lett; 1988 Dec; 94(3):349-54. PubMed ID: 3264604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
